COPD Study Leveraging Technegas and AI-Driven Lung Analysis

Cyclopharm Limited (ASX: CYC) is pleased to announce a new clinical research collaboration with Macquarie University and Macquarie University Hospital to evaluate a novel treatment approach for patients with severe chronic obstructive pulmonary disease (COPD). The study, known as the Endoscopic Segmental Sealant Ablation (ESSA) Study, will be led by Professor Alvin Ing, Professor of Respiratory Me